Use of artificial intelligence/machine learning (AI/ML) to enhance the step pediatric excipient database
Ended Awarded Last action
- Contract number
- 75N93024F00005
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,193,090
Award facts
- Contract value 100% obligated
- $1,193,090.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $1,193,090 |
About this award
This is a cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Advanced Bioscience Laboratories, Inc. (ABL) to use artificial intelligence/machine learning (AI/ML) to enhance the STEP pediatric excipient database. The contract, valued at $1,193,090.00, has a period of performance through September 30, 2025. It is not a set-aside contract.
The contract is part of a larger $98.9 million Indefinite Delivery Vehicle (IDV) with NIAID called "Resources to Advance Pediatrics and HIV Prevention Science," which supports a range of preclinical development services. ABL is an experienced federal contractor, holding several IDVs with NIAID, the National Institute of Neurological Disorders and Stroke, and the National Cancer Institute, focused on biopharmaceutical research and development, including manufacturing, testing, and clinical support for infectious disease countermeasures and cancer prevention initiatives.
Quick answers
Who was awarded contract 75N93024F00005?
75N93024F00005 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 1, 2024.
How much is contract 75N93024F00005 worth?
The government has obligated $1,193,090 on 75N93024F00005.
Is contract 75N93024F00005 an order under another contract?
Yes. 75N93024F00005 is a delivery order under 75N93023D00001, an indefinite delivery contract, on Resources to Advance Pediatrics and HIV Prevention Science.
Was contract 75N93024F00005 competed?
The extent of competition for 75N93024F00005 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award